THE EFFECTIVENESS OF BISOPROLOL IN PATIENTS WITH RHEUMATIC  HEART DISEASE WITH CHRONIC HEART FAILURE

Makhmudova M.S., Shukurdjanova S.M., Nuritdinova N.B.

dc.contributor.author	Makhmudova M.S., Shukurdjanova S.M., Nuritdinova N.B.
dc.date.accessioned	2023-05-07T13:58:55Z
dc.date.available	2023-05-07T13:58:55Z
dc.date.issued	2023
dc.identifier.issn	2181-0974
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/7581
dc.description.abstract	After 3 months of treatment, the first group showed a decrease in proinflammatory cytokines TNF-alpha by 22.6%, interleukin-6 by 25.3%.In the second group, TNF-alpha decreased by 15.8%, interleukin-6 decreased by 18.1%.There were improvements in the clinical condition and quality of life, an increase in exercise tolerance. Bisoprolol is an effective drug for the treatment of rheumatic heart defects complicated by CHF II-III FC, having a beneficial effect on immunological parameters (reducing the amount of pro-inflammatory cytokines) and improving the quality of life.	en_US
dc.language.iso	en	en_US
dc.publisher	ИННОВАЦИОННЫЙ ПРОГРЕСС В ИССЛЕДОВАНИЯХ ВНУТРЕННЕЙ МЕДИЦИНЫ \| 2023 \| ЖУРНАЛ КАРДИОРЕСПИРАТОРНЫХ ИССЛЕДОВАНИЙ	en_US
dc.subject	bisoprolol, immunological parameters and quality of life, rheumatic heart defects, CHF	en_US
dc.title	THE EFFECTIVENESS OF BISOPROLOL IN PATIENTS WITH RHEUMATIC HEART DISEASE WITH CHRONIC HEART FAILURE	en_US
dc.type	Thesis	en_US